In last trading session, Xeris Biopharma Holdings Inc (NASDAQ:XERS) saw 1.73 million shares changing hands with its beta currently measuring 0.68. Company’s recent per share price level of $4.79 trading at $0.15 or 3.23% at ring of the bell on the day assigns it a market valuation of $767.14M. That closing price of XERS’s stock is at a discount of -26.72% from its 52-week high price of $6.07 and is indicating a premium of 61.17% from its 52-week low price of $1.86.

For Xeris Biopharma Holdings Inc (XERS), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.33. Splitting up the data highlights that, out of 3 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 3 see the stock as a Buy. 0 analyst(s) advised it as an Underweight.

Xeris Biopharma Holdings Inc (NASDAQ:XERS) trade information

Upright in the green during last session for gaining 3.23%, in the last five days XERS remained trading in the red while hitting it’s week-highest on Friday, 05/09/25 when the stock touched $4.79 price level, adding 8.41% to its value on the day. Xeris Biopharma Holdings Inc’s shares saw a change of 41.30% in year-to-date performance and have moved -7.17% in past 5-day. Xeris Biopharma Holdings Inc (NASDAQ:XERS) showed a performance of 9.36% in past 30-days.

Wall Street analysts have assigned a consensus price target of 4 to the stock, which implies a fall of -19.75% to its current value. Analysts have been projecting 4 as a low price target for the stock while placing it at a high target of 4. It follows that stock’s current price would jump 16.49% in reaching the projected high whereas dropping to the targeted low would mean a gain of 16.49% for stock’s current value.

Xeris Biopharma Holdings Inc (NASDAQ:XERS)’s Major holders

BLACKROCK INC. is the top institutional holder at XERS for having 10.33 million shares of worth $23.25 million. And as of 2024-06-30, it was holding 6.9649 of the company’s outstanding shares.

The second largest institutional holder is VANGUARD GROUP INC, which was holding about 7.66 million shares on 2024-06-30. The number of shares represents firm’s hold over 5.1615 of outstanding shares, having a total worth of $17.23 million.

On the other hand, VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and iShares Trust-iShares Russell 2000 ETF are the top two Mutual Funds which own company’s shares. As of Dec 31, 2024, the former fund manager was holding 4.22 shares of worth $20.22 million or 2.70% of the total outstanding shares. The later fund manager was in possession of 3.71 shares on Mar 31, 2025, making its stake of worth around $17.76 million in the company or a holder of 2.37% of company’s stock.